April 24, 2023
Two different fights
The big news in the diabetes toy world was the approval of the Medtronic 780G. The big news in the diabetes/obesity drug world was Lilly’s new study which will pit Mounjaro against Wegovy head-to-head. Each piece of news represents a fight, one for survival the other for supremacy. Let’s take the Medtronic news first.
Medtronic CEO Geoff Martha has stated many times that the 780G will reverse the tide for Medtronic in diabetes. That all their problems will go away, and they will be competitive again. Given that a broken clock is right twice a . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
